NCT00168090View on ClinicalTrials.gov

Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2001

Study Completion Date

May 31, 2006

Conditions
Von Willebrand DiseaseBlood Coagulation DisordersBlood Platelet DisordersHematologic Disease
Interventions
DRUG

Blood coagulation Factor VIII and vWF, human

Trial Locations (1)

53201-2178

Milwaukee

Sponsors

Lead Sponsor

CSL Behring
All Listed Sponsors
lead

CSL Behring

INDUSTRY